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Abstract
We investigated factors that influence choice of colorectal
cancer (CRC) screening test and assessed the most- and least-
preferred options among fecal occult blood testing (FOBT),
flexible sigmoidoscopy, colonoscopy, and double contrast barium
enema among adults with varied race, gender, and geographic
region demographics. Mixed methods data collection consisted
of 10 focus group interviews and a survey of the 93 focus group
participants. Participants were ≥50 years of age and reported
not having been screened for colorectal cancer in the last ten
years. Analyses examined differences by race, gender, and
geographic location. Participants had modest knowledge about
CRC and there were fewer correct answers to knowledge
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questions by African Americans. Participants recognized value
of early detection, and identified health symptoms and their
doctor's recommendation as influential for obtaining CRC
screening. They chose colonoscopy and FOBT as the most
preferred tests, while barium enema was least preferred. The
analysis revealed intra-group variations in preference, though
there were no significant differences by race, gender, or
location. Openness of discussing this sensitive topic, lack of
knowledge about colorectal cancer and screening costs, and
diversity of preferences expressed within study groups suggest
the importance of patient-physician dialogue about colorectal
cancer screening options. New approaches to promoting
colorectal cancer screening need to explore methods to
facilitate patients establishing and expressing preferences
among the screening options.
Introduction
Colorectal cancer (CRC) is the third most frequently diagnosed cancer
among men and women in the United States and the second leading cause of
cancer death [1]. It has a lengthy, detectable, premalignant phase during
which a simple intervention (polypectomy) can be used to prevent
progression to more advanced stages of cancer [2–5]. When detected early,
more than 90% of persons with the disease live at least five years beyond the
diagnosis. Unfortunately, only 37% of colorectal cancers are diagnosed
before they have metastasized [6]. Methods commonly available for
screening include fecal occult blood testing (FOBT) and visualization of the
area either with a sigmoidoscopy (rigid or flexible), a colonoscopy, or a
double contrast barium enema [7]. Despite the availability of these
procedures, screening rates for CRC are quite low. Only 26.5 and 24.2% of
adults aged 50 years and over had used a home stool test kit within the past
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two years, and 53.5 and 57.1% reported ever having a sigmoidoscopy or
colonoscopy examination in 2004 and 2006, respectively, based on
Behavioral Risk factors Surveillance system [8].
Previous research demonstrates that most adults believe in routine cancer
screening, reasons why they seek screening, and a knowledge gap, especially
among women when it comes to cervical and colorectal cancers [9–12].
Personal preference is important in screening [13], and patients vary in their
acceptance of tests [14]. A growing body of literature has focused on patient
preferences for CRC screening [10, 15, 16]. Beeker et al. identified factors
that predispose individuals to be screened for CRC, such as knowledge of
the risks [10]. They also identified enabling factors, such as costs, and
reinforcing factors, such as interactions with health providers, friends, and
family. In a call for further research, Beeker et al. also suggested that future
interventions should be tailored for specific populations such as women,
racial, and ethnic groups [10].
Leard et al. has explored preferences for method of CRC screening among
males and females who were mainly Caucasian (87%) [15]. For these
individuals, the preferred screening methods, from most to least, were
colonoscopy, FOBT, barium enema, and flexible sigmoidoscopy. Pignone et
al. examined preferences for CRC screening after receiving descriptive
information, after information about test performance, and with information
about out-of-pocket costs [16]. Taken together, the Leard & Pignone studies
assess screening preferences among primarily Caucasian, non-rural
populations. Thus, they provide little evidence of preferences for individuals
with diverse ethnic/racial backgrounds, and do not provide qualitative
assessment of the reasons individuals seek screening and the reasons for a
preferred screening test for CRC. Given these gaps in previous research, we
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investigated factors that influence choice of a screening test. We assessed
the most- and least- preferred tests among four tests (FOBT, flexible
sigmoidoscopy, colonoscopy, and double contrast barium enema) for study
groups that varied by gender, race/ethnicity, and geographic region. The
goal was to guide the development of a web-based tool to help patients
choose among the screening options and then test the tool in a randomized
controlled trial [17, 18].
Methods
Design
We employed a triangulation mixed methods design with both qualitative
and quantitative data collected, but with a priority given to the qualitative
analysis [19]. The approach to leveraging both data sources together is
gaining popularity in the social and health sciences [19–27]. In a
triangulation mixed methods design, both qualitative and quantitative data
are collected concurrently, and by integrating the results, a more robust and
complete understanding is possible than the use of either data source alone
(Fig. 1). Based on gaps in the literature, the study was designed to enroll
previously unscreened individuals, and to include both African American
and rural participants. The University of Michigan Institutional Review
Board approved this study.
Recruitment of Participants
Participants were recruited by telephone using a stratified random sampling
process reported previously [28]. The stratification was based on three
geographic areas: urban, semi-urban, and semi-rural areas and sampled
within zip and area codes that represented these three areas. To select
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potential participants for each focus group, individuals were called using a
computer-aided telephone interviewing (CATI) system. The intent of the
initial telephone interview was to determine if the person was eligible and
interested in participating. Eligibility criteria consisted of individuals with
self-reported age between 50 and 70 years at time of telephone interview,
and people who had not been screened for colon cancer within the last ten
years. Approximately equal distribution by race was sought.
Data Collection
Following this CATI screening, 10 semi-structured focus group interviews
were conducted. Approximately equal numbers of African American and
Caucasian American adult women and men in three Michigan communities
comprised the focus groups. The focus group interviews were gender-
specific, moderated by a same-sex interviewer (both were Caucasian), and
lasted approximately two hours [28]. For feasibility issues, one male focus
group included both African Americans and Caucasian Americans; all
others were race specific.
Prior to the interview, participants completed a CRC knowledge and beliefs
instrument consisting of 21 multiple-choice items. Major domains
addressed risk factors from lifestyle, personal characteristics and family
history, effectiveness of early detection, screening tests, and beliefs about
risks of surgery previously identified as important among African
Americans relative to breast cancer [29]. During the focus group,
participants were asked: their reasons for not being checked for CRC, their
reasons for being checked, factors that would influence them to be checked,
and their awareness of CRC screening. After this questioning, the facilitator
handed out a summary sheet of basic features about four tests to check for
CRC [i.e., FOBT, flexible sigmoidoscopy, colonoscopy, and double contrast
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barium enema (Table 1)]. Using this summary sheet as a guide, the
facilitator reviewed each of the four tests and then led a discussion about the
reasons for choosing and not choosing each test.
Next, the focus group participants wrote their decision in private on a slip of
paper about which tests were their most and least favorite and then with the
group discussed reasons for their choices. Rather than simply recalling
information from the handout, the participants framed their reasons in their
own words. Follow-up questions addressed the participants' thoughts about
insurance coverage for tests and their information sources for learning about
cancer. Following the focus group interview, the participants provided
demographic information. This data collection yielded 268 pages of
transcription, from approximately 40 h of videotape, and survey results on
knowledge, beliefs and demographics data.
Data Analysis
We conducted a mixed methods analysis because we collected both
quantitative and qualitative data (knowledge and beliefs assessment
instrument and demographics, and focus group interviews respectively)
[20]. Quantitative data analysis was conducted using SPSS. Comparisons
between African American and Caucasian participants were done using t-
test and chi square as appropriate for the variable with adjustments made for
multiple comparisons. Qualitative data analysis was conducted using QSR
N6. Specifically, the QSR N6 software program was used for storing data,
creating categories, and searching for evidence in the database. During the
coding process of qualitative analysis, intercoder agreement between one of
the investigators (JC) and the focus group interviewer was excellent. There
was 88% agreement on codes for the question on reasons to be checked for
colorectal cancer, and 100% agreement on the question about factors that
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would influence or persuade one to be checked for colorectal cancer. To
enhance validity, evidence from the text was sought through the N6 analysis
to corroborate the identified themes.
Results
Demographics
There were 93 participants in the focus groups and these ranged in size from
5 to 12 people per group. The demographic features of the study participants
overall and by race are summarized in Table 2. The African American
participants were significantly older (t = 2.41, P = 0.01), had more children
(t = 2.34, P = 0.01) and grandchildren (t = 1.64, P = 0.03), had fewer years
of education (t = 1.96, P = 0.02), and were more likely to have an annual
household income less than $30,000 (chi square = 5.22, P = 0.02). More
African Americans (chi square = 1.75, P = 0.03) reported ever having a
health maintenance examination (HME), and the most recent HME was
more recent than Caucasians (t = 2.16, P = 0.03).
Quantitative survey data yielded insight into the personal knowledge and
beliefs individuals had about CRC. The qualitative data led to themes about
reasons why individuals should be tested, what would encourage individuals
to be tested, and the role of their physician and insurance in screening.
Finally, the qualitative focus group data were transformed by coding and
quantification to provide rank ordering of volunteered preferences for
screening tests and to include quotes to support reasons for choices of tests.
Personal Knowledge and Beliefs of Colon Cancer
To highlight areas of least understanding among the participants, Table 3
compares by race the number and percentage of participants with
7
uncertain/incorrect responses about knowledge and belief questions.
Overall, participants had modestly good understanding of lifestyle risks
associated with CRC (i.e., smoking, age, foods high in fat, and low in fiber).
They were, however, uncertain as to whether risks changed based on the
ethnicity or gender of a person. For the most part, they were aware of the
need for early detection, benefits of early detection, and screening tests
available (i.e., FOBT, flexible sigmoidoscopy, colonoscopy, and double
contrast barium enema). They were uncertain about the relationship of
family history (i.e., breast, prostate, ovarian, CRC or colorectal polyps) to
CRC. Further analysis showed that there were no significant gender
differences on any knowledge item (P >.05). Significantly more African
Americans than Caucasians (chi square = 4.99, P = 0.02) did not know
increased fiber consumption is a means to reduce risk. In addition, more
African Americans responded incorrectly or were uncertain of the risk of
family history for CRC (chi square = 9.135, P < 0.002) and ovarian cancer
(chi square = 4.18, P = 0.03). Far more African Americans (57% vs. 31% for
Caucasians, chi square = 6.24, P = 0.01) were uncertain or incorrectly
believed that surgery for CRC will cause cancer to spread.
Reasons for Testing
As shown in Table 4, participants in the focus groups identified specific
reasons about why they should be tested for colorectal cancer. Of multiple
reasons mentioned, the most frequently discussed were: prevention or early
detection (n = 38), health symptoms or problems (n = 28), family genetics
or family history (n = 14), and age of a person (n = 10). Several individuals
(n = 10) indicated that they had never thought about being checked.
Additional factors cited were: other people who have had cancer, a doctor's
recommendation, its prevalence today, and publicity in the news media.
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Others commented about how testing simply would prolong their lives.
The participants frequently mentioned early detection as a primary reason to
be tested. They indicated that detection of colon cancer early enhances the
probability of recovery, provides early signs of polyps that could be excised,
removes the possibility of the spread of cancer, and makes colorectal cancer
easier to treat. Health problems such as constipation, blood in the stool,
excessive straining, or general problems with the rectum or bowel would
also lead some participants to testing. Someone in the family with cancer or
prior testing for cancer also was provided as a reason to lead individuals to
colorectal cancer testing. Several individuals talked about their family
histories of cancer, such as their father's or cousin's cancer. Although they
did not mention a specific age, they commented about how they need testing
as they age or because illness occurs more frequently with older age. A
curious finding was that women in two groups, one Caucasian and one
African American, spoke about how they avoid thinking about colorectal
cancer.
Factors Encouraging Testing
We asked focus group participants to identify factors that would influence
or encourage them to be screened. As shown in Table 4, the five most
frequently discussed influences were physical symptoms (n = 33), a doctor's
recommendation (n = 31), knowledge about colorectal cancer (n = 21),
family history (n = 20), and availability of insurance coverage (n = 12).
Other less frequently reported influences were friends, experiences of others
with cancer, age when a CRC check is recommended, additional free time
after retirement, availability of a “simple” test, and the importance of early
detection.
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Physician's Role in Testing
Participants varied in their perspectives of the role their physicians should
take in test choice (Table 4). Most participants said they leave test choice up
to the physician because of their training, knowledge, and inclination to be
directive (n = 23). A subset of participants anticipated a middle path of
assessing the pros and cons of each screening test together with their
physician, and then making a decision about which procedure (n = 13) to
use. Only two participants indicated that the choice was ultimately their own
to make. The participants also discussed the importance of rapport and trust
in their physicians.
Insurance as a Factor
As shown in Table 4, many participants reported that test cost and insurance
coverage had a direct effect on their test choices (n = 14). Participants had
difficulty indicating how much money they would be willing to spend on an
un-reimbursed test because they did not know the costs of different
screening tests (n = 5). They were aware, however, that the colonoscopy and
barium enema tests are more costly, and several recommended that patients
should discuss costs with their physicians. Some thought that even though
they were jobless or uninsured, Medicare would cover the costs of the test.
Only two stated insurance was not necessary and they would still get tested
even not having insurance.
Test Preferences
Table 5 illustrates participants most and least favored test for CRC
screening. In all, 74 provided an opinion about most preferred test. The
ordering by most preferred test is: colonoscopy (49%) fecal occult test
(39%), barium enema (7%), and flexible sigmoidoscopy (5%). Reasons
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given for preferring colonoscopy were thoroughness of information
provided and the lack of need for additional follow-up tests. They viewed it
as accurate, relatively painless because of the anesthesia, and essentially the
best available test because, “it's more involved, but once you get through it
you're home free for at least ten years.” Reasons for preferring fecal occult
testing were its brief test-retest interval (“I can get it done annually and if
blood is found, then I would take the other test.”), simplicity, convenience,
and personal privacy. Moreover, participants saw it as a preliminary screen
before more invasive testing was required, “So first I have to know if I have
a problem, and then I'm going to do something about it.”
While there were trends found in subgroup analyses, there were no
statistically significant differences by gender, race and geography. More
Caucasians than African Americans preferred fecal occult test (46% vs.
30%), while more African Americans than Caucasians preferred
colonoscopy (55% vs. 44%). There was no gender difference in preference
for colonoscopy; whereas, slightly more males than females (43% vs. 36%)
preferred fecal occult test. Urban and semi-urban participants tended to
prefer colonoscopy to fecal occult testing (55% and 50% for colonoscopy,
35% and 42% for fecal occult blood test, respectively) although the semi-
rural participants were equally divided between preferring colonoscopy
(38%) and fecal occult testing (38%).
Regarding least-preferred tests, 64 gave an opinion (Table 5). Over half of
the participants least preferred barium enema (53%) followed by
colonoscopy (22%), flexible sigmoidoscopy (14%), and finally fecal occult
testing (11%). Reasons for ranking barium enema as least-preferred were:
the need to have barium and air pumped into the colon (“the air would just
be too much”), the perception that the test may require follow-up testing
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(“need to have a colonoscopy or something if you had polyps”), and the
length of time required for barium clearance (“the recovery time”). Finally,
reasons given for ranking colonoscopy as the least preferred were: the need
for anesthesia (“I like to avoid any kind of anesthesia”), invasiveness, and
potential pain (“I wouldn't want to have that probe stuck up…it would be
quite discomfortable”).
There were trends, but no statistically significant differences by race,
gender, or location for the least-preferred test. More Caucasians than
African Americans (22% vs. 4%) rated flexible sigmoidoscopy as least
preferred (“What about the other two-thirds of the colon?”). More females
than males (62% vs. 40%) considered a barium enema to be the least-
preferred test (“I'd have to get rid of it (gas) for days”). More males than
females rated colonoscopy as least preferred (28% vs. 18%) and for diverse
reasons (“the time, pain, discomfort, having somebody take you to the
hospital and all that”). In terms of their least-favorite test, urban and semi-
urban participants were more favorable about a flexible sigmoidoscopy test
than the semi-rural participants, and the semi-rural participants were more
favorable than the semi-urban participants toward the fecal occult blood
test.
Discussion
This study highlights the complex factors that go into individuals choosing a
colorectal cancer screening test. Overall, the study participants had modest
knowledge about colorectal cancer, results that have been elicited in prior
research [9, 10]. Despite some differences by race, and possible trends by
race, gender and geographic location, the overall intra-group variation
suggests that regardless of the sub-population studied, there will be
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individual variation that physicians should explore in helping patients
choose and be screened for CRC. In the knowledge and beliefs evaluation,
African American participants had higher numbers of uncertain or incorrect
answers. This suggests physicians should take care to fully disseminate
information and provide opportunities for discussion especially with their
African American patients.
Regarding reasons for testing, participants focused on early detection and
health problems that would signal a need to be tested. Physical symptoms
and the advice of their physicians also encouraged them to proceed with
testing, results consistent with previous findings [10]. Leaving the decision
up to their physician was a role many were comfortable with, and, while
insurance to pay for the tests was viewed as important, some felt that tests
were needed regardless of the availability of insurance, even though they
were uncertain about how much these tests cost. For all participants, the
most favored test was colonoscopy (consistent with Leard et al., but
contradictory to Pignone, et al.) and the least preferred test was the barium
enema [15, 16]. The study groups that favored the colonoscopy tended to be
the Caucasian males from urban and semi-urban settings. The study groups
that were least favorable to the barium enema were females from the urban
and semi-urban areas.
As the study participants were not chosen at random, this may limit the
generalizability of findings. There were inadequate numbers to achieve
statistical significance for many of the sub-analyses. The number of
participants, the self-reported data and focus group methodology limitations
may have precluded full elucidation of relevant perspectives. Still the data
transformation procedure used does provide a view on relative importance
of various factors based on frequency raised. A potential concern is that the
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information sheet about the four screening tests given to participants could
bias their responses, but they independently arrived at their choice after
discussing the advantages and disadvantages of each test. Findings might
have been different among adults with more recent screening experience,
and new screening tests such as virtual colonoscopy or DNA stool test were
not addressed in the focus groups. Finally, because the study participants
were all of average risk for colorectal cancer, findings may be different
among adults at increased risk.
This study represents an assessment of preferences for different colorectal
cancer screening tests by men and women, African Americans and
Caucasians, and by individuals from different types of communities. This
predominantly qualitative study adds to that of Beeker et al. by further
elucidating the participants' preferences regarding available screening
options for CRC [10]. There is striking diversity in perspectives within these
groups in CRC screening preference and this reinforces the need for
physicians to individualize screening tests and to discuss and negotiate with
individuals about their choice of tests. Despite the sensitive nature of the
subject matter, the participants in this study openly discussed their reasons
for screening and the attitudes towards each test. Patients appear to need an
open discussion of the pros and cons of each test, especially if they are
uncertain or unknowledgeable about colorectal cancer.
Practical Implications
Determining a patient's preferences among the four screening tests is not a
simple task. A simple tri-fold handout or website with just the facts really
cannot adequately address many of the variables adults consider. Simply
giving patients a choice from among the screening options does not appear
to improve screening rates [30–33]. Rather, an effective tool for CRC
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screening decision-making needs to provide decision support and preference
clarification with regards to the variables and domains raised in this
research.
Consequently, we used the findings from the current investigation and
created an interactive decision aid called Colorectal Web to promote
colorectal cancer screening [17]. The current program can be reviewed at
http://colorectalweb.org/; login: test; password: test. The program focuses
on helping users establish a choice among the screening options through a
preference clarification activity. The activity allows users to select three
issues they are concerned about in checking for colon cancer. The possible
issues include pain, preparation required, accuracy, frequency, extent of
invasiveness of the test, and cost. Based on this research, Colorectal Web
contains education topics specific to gender, race, and other risk factors for
colorectal cancer, and the content was generated specifically to address
misperceptions based on the knowledge and belief items and concerns
identified in the qualitative findings. In a randomized controlled trial, the
tool developed based on this research proved to be quite effective in getting
users to complete colorectal cancer screening [18]. The probability of being
screened for colorectal cancer after 24 months in the Colorectal Web
intervention study arm was more than threefold greater compared to the
control arm (OR = 3.23, 2.73–3.50 95% Confidence Interval).
Unscreened patients can clearly develop a preferred screening approach for
colorectal cancer, though the factors influencing the preference are manifold
and complex. Remaining unanswered questions for future research are how
to establish efficiently a preferred screening method; how patients can
express their preferences to their clinical providers; how providers respond
to requests for the preferred screening option and does having a clear
15
preference lead to more screening in a variety of patient populations. As the
web-based intervention developed from this project lead to increased
screening, research on how to disseminate this program, and whether there
are gender and racial differences when used on a broader scale are questions
that merit further inquiry. One project underway is examining whether
sending the patient's doctor the results of the preference generated through
the Colorectal Web preference clarification activity leads to more screening.
View larger version
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Fig. 1. Mixed methods triangulation design of the factors
influencing choices for colorectal cancer screening
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Table 1. Summary of four tests to check for colorectal cancer
Fecal occult
testing
Flexible
sigmoidoscopy
Colonoscopy
Double
contrast
barium enema
Purpose
Chemically
tests for
blood in
stool
Directly
looks in last
third of colon
Directly
looks in all of
colon
Uses an X
ray to look
in the colon
How to do
it
Patient
collects
stool on a
stick and
touches the
stool to a
special card
Doctor
inserts a 2
foot long
flexible
instrument
into the colon
Doctor
inserts a 5–6
foot long
flexible
instrument
into the colon
Radiologist
inserts air
and barium
into the
colon, then
X rays are
taken
Preparation
Small
Diet low in
lightly
cooked
meats and
certain
vegetables
Moderate
Take a
medication
that
stimulates a
bowel
movement
and use an
enema to
clean out the
Intense
Takes several
medications
that
stimulates a
bowel
movement, or
fluids by
mouth to
clean out the
Moderate
Take a
medication
that
stimulates a
bowel
movement
and use an
enema to
clean out
23
stool stool the stool
Pain None
Mild to
moderate
Moderate to
severe,
Requires
anesthesia,
Risk of
perforation
Mild to
moderate
Test
accuracy
Fair
Good-only
1/3 of colon
seen; Limited
if stool still
in bowel
Excellent-
limited only
if bowel still
has stool
inside
Excellent-
limited only
if bowel
still has
stool inside
How often? Annually Every 5 years
Every 10
years
Every 10
years
Other
testing
involved?
If blood
found, need
colonoscopy
Biopsy done
at time of
test, may
need
colonoscopy
if
abnormalities
found
Biopsy done
at time of test
If abnormal,
need
colonoscopy
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Table 2. Demographics of participants
African
Americans N =
51 n (%)
Caucasian
Americans N =
42 n (%)
Both N =
93 mean or
(%)
P value
Age (mean, years) 58 60 60 <0.001
Marital status
 Married 22 (52%) 25 (60%) 46% ns
 Single 6 (14%) 10 (24%) 21% ns
 
Divorced/separated
8 (19%) 11 (26%) 29% ns
 Widowed 6 (14%) 6 (14%) 12% ns
Mean number of
children
3.5 2.4 2.9 <0.001
Mean number of
grandchildren
5.0 3.2 4.2 <0.001
Self-report of
health
 Excellent 8 (22%) 9 (21%) 21% ns
 Good 22 (60%) 26 (62%) 57% ns
25
 Fair 6 (16%) 6 (14%) 20% ns
 Poor 1 (3%) 1 (2%) 3% ns
Years of education 13 14 14 <0.001
Ever Had HME 49 (96%) 37 (88%) 86 (92%) <0.001
Years Since Last
HME
1.1 2.1 1.5 0.034
Frequency of HME
 Yearly 30 (59%) 17 (41%) 47 (57%) ns
 Every 2–3 years 9 (18%) 5 (12%) 14 (17%) ns
 Every 4–10
years
9 (18%) 13 (31%) 22 (27%) ns
Health Insurance
 Managed care 8 (16%) 7 (17%) 15 (16%) ns
 Private
Insurance
17 (33%) 12 (29%) 29 (31%) ns
 Federal
(MediCare/Caid,
VA)
20 (39%) 15 (36%) 35 (37%) ns
 Self-pay 4 (8%) 8 (19%) 12 (13%) ns
26
Household income
 < $30,000 31 (61%) 16 (38%) 47 (50%) <0.001
 > $30,000 19 (37%) 26 (62%) 45 (48%)
ns = non-significant
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Table 3. Knowledge and beliefs about colorectal cancer
Knowledge and beliefs items
Incorrect or
uncertain
African
Americans
Incorrect or
uncertain
Caucasian
Americans
P value
Risk factors from lifestyle
Smoking increases the risk of getting
colon cancer (True)
27 (54%) 15 (36%) 0.09*
Eating foods high in fiber increases
the risk of getting colon cancer
(False)
16 (31%) 5 (12%) 0.02
Eating foods high in fat increases the
risk of getting colon cancer (True)
17 (34%) 8 (19%) 0.08*
Risk factors based on personal
characteristics
The risk of getting colon cancer
increases as a person gets older than
50 (True)
10 (20%) 3 (7%) 0.07*
African Americans are at higher risk
of getting colon cancer (False)
46 (90%) 36 (88%) ns
Caucasians are at higher risk of
getting colon cancer (False) 44 (86%) 32 (76%) ns
28
Men are at higher risk than women
for getting colon cancer (False)
43 (88%) 39 (93%) ns
Risk based on family history
A family history of colon cancer
increases a person's risk for getting
colon cancer (True)
18 (37%) 4 (10%) 0.002
A family history of breast cancer
increases a person's risk for getting
colon cancer (True)
39 (77%) 35 (83%) ns
A family history of prostate cancer
increases a person's risk for getting
colon cancer (False)
43 (84%) 35 (83%) ns
A family history of ovarian cancer
increases a person's risk for getting
colon cancer (True)
36 (71%) 37 (88%) 0.03
A family history of colon polyps
increases a person's risk for getting
colon cancer (True)
25 (49%) 13 (31%) 0.06*
Effectiveness of early detection
Tests that check for colon cancer can
find it at an early stage (True)
6 (12%) 3 (7%) ns
Treating colon cancer at an early
29
stage will usually result in its cure
(True)
18 (37%) 5 (12%) 0.006
Finding colon cancer when it is
advanced usually results in an early
death (True)
31 (62%) 24 (57%) ns
Screening tests
Colon cancer can be found by
checking for blood in the stool (True)
16 (32%) 15 (36%) ns
Colon cancer can be found by using a
blood test (False)
36 (71%) 23 (55%) ns
Colon cancer can be found by having
a barium enema and taking an x-ray
(True)
30 (60%) 26 (65%) ns
Colon cancer can be found by having
a doctor insert a flexible fiber optic
endoscope and directly looking for
cancer (True)
19 (38%) 11 (27%) ns
Beliefs
Most all patients who have surgery
for colon cancer will have to have a
colostomy (False)
31 (61%) 22 (54%) ns
If you have surgery for colon cancer,
30
the cancer will spread through the
blood to other parts of the body
during surgery (False)
29 (57%) 13 (31%) 0.01
*. non-significant values reported to illustrate trend
ns =non-significant
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Table 4. Themes in choice for colorectal cancer screening
Themes and sub-
themes
Quotes and attributions*
Reasons why
they should be
tested
Prevention or
early detection
(n = 38)
“In case you got it, catch it early.” AA female FG,
Urban area
“Could be treated easier if you get it early.” Mixed
males FG, Semi-rural area
“Early detection means quicker or a better chance of
recovery.” CA male FG, Semi-urban area
Health
symptoms or
problems (n =
28)
“I've heard blood in the stool.” AA female FG, Urban
area
“There is a whole bunch of symptoms, blood,
irregular bowel movement.” CA male FG, Semi-urban
area
“A lot of strain, strain causes problems, too.” AA
female FG, Semi-rural area
32
Family genetics
or family history
(n = 14)
“If someone in the immediate family tested with
colon cancer.” AA female FG, Urban area
“There is cancer in my family already.” CA male FG,
Semi-urban area
“Heredity, right?” Mixed male FG, Semi-rural area
Age of the
individual (n =
10)
“If you're a certain age, you should be checked,
right?” AA male FG, Semi-urban area
“As you grow older, you have problems with
constipation.” AA female FG, Semi-rural area
“I think now that I've gotten older, I think I probably
would.” AA female FG, Urban area
Haven't thought
about it (n = 10)
“If we thought about it, and believed in doing it, we
would do it!” CA female FG, Urban area
“I never really thought about being tested.” AA
female FG, Semi-urban area
“We don't think about it.” CA female FG, Urban area
Factors
encouraging
testing
Physical
33
symptoms (n =
33)
“Blood in your stool.” CA female FG, Semi-rural area
“Complications of the digestive system,
irregularities.” CA males FG, Semi-urban area
“Rectal pain or bleeding.” CA males FG, Urban area
Doctor
recommendation
(n = 31)
“The doctor tell(s) you, ‘you need this done’.” Mixed
male FG, Semi-rural area
“If the doctor insisted.” CA female FG, Urban area
“Doctor saying it's time you have one.” CA female
FG, Urban area
Information
about colon
cancer (n = 21)
“The Today Show with Katie Couric.” CA female FG,
Semi-urban area
“A news feature that I might take to heart.” AA
female FG, Semi-urban area
“Maybe more public awareness.” CA female FG,
Semi-rural area
Family history (n
= 20)
“There is a high risk of cancer in my family.” AA
female FG, Semi-urban area
“Family member being diagnosed.” CA female FG,
Semi-rural area
34
“My father had prostrate cancer and it makes you
think.” CA female FG, Semi-rural area
Available
insurance to
cover costs (n =
12)
“Because it's covered by insurance.” AA female FG,
Urban area
“In two years I will have Medicare, and then I can go
and get tested.” CA female FG, Urban area
“It would depend on who was gonna pay for it.” CA
female FG, Urban area
Role of
physician in
choice
Physician
decides (n = 23)
“I think I would ask my doctor what he thought about
it.” AA female FG, Urban area
“I want the doctor to make the decision.” Mixed male
FG, Semi-rural area
“He would know more, which one of these tests would
be best for me.” AA male FG, Semi-urban area
Assess pros and
cons (n = 13)
“The doctor would explain all of the avenues, and
explain each one.” CA female FG, Semi-urban area
“I would need to know what all of the tests were.” CA
35
female FG, Urban area
“Get his ideas, the pros and cons to each one.” CA
female FG, Semi-rural area
Physician asks
you (n = 2)
“I think that he would ask you what you would want.”
AA female FG, Urban area
“He would leave it up to you.” AA female FG, Urban
area
Insurance as a
factor
Important factor
(n = 14)
“That's part of the pain – if you don't have insurance.”
CA male FG, Semi-urban area
“Most insurances will cover that.” AA female FG,
Semi-rural area
Uncertain about
costs of tests (n
= 5)
“How much would you be willing to pay?” AA female
FG, Semi-rural area
“I don't have an ideas how much these tests cost.” CA
female FG, Semi-rural area
Not necessary (n
= 2)
“If I didn't have insurance, and the doctor said that I
really needed it, I would have it any way.” CA female
FG, Semi-urban area
“I wouldn't even ask how much this will cost me,
36
when it came to tests.” CA female FG, Semi-urban
area
*. Due to space limitations, not all factors are presented
AA-African American
CA-Caucasian American
FG-Focus group
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Table 5. Choice of most favorable and least favorable test by
ethnicity, gender, and location*
n Colonoscopy
Fecal
occult
Double contrast
barium enema
Flexible
sigmoidoscopy
All
respondents%
Most favored 74 36 (49%)
29
(39%)
5 (7%) 4 (5%)
Least favored 64 14 (22%)
7
(11%)
34 (53%) 9 (14%)
Ethnicity
African
American
 Most
favored
33 18 (55%)
10
(30%)
4 (12%) 1 (3%)
 Least
favored
28 7 (25%)
3
(11%)
17 (61%) 1 (4%)
Caucasian
 Most
favored
41 18 (44%)
19
(46%)
1 (2%) 3 (7%)
38
 Least
favored
36 7 (19%) 4
(11%)
17 (47%) 8 (22%)
Gender
Females
 Most
favored
39 19 (49%)
14
(36%)
4 (10%) 2 (5%)
 Least
favored
39 7 (18%)
3
(8%)
24 (62%) 5 (13%)
Males
 Most
favored
35 17 (49%)
15
(43%)
1 (3%) 2 (6%)
 Least
favored
25 7 (28%)
4
(16%)
10 (40%) 4 (16%)
Location **
Urban
 Most
favored
20 11 (55%)
7
(35%)
0 (0%) 2 (10%)
 Least
favored
18 2 (11%)
1
(6%)
12 (67%) 3 (17%)
Semi-Urban
39
 Most
favored
28 9 (50%) 16
(42%)
2 (5%) 1 (3%)
 Least
favored
29 7 (24%)
4
(14%)
13 (45%) 5 (3%)
Semi-rural
 Most
favored
16 6 (38%)
6
(38%)
3 (19%) 1 (6%)
 Least
favored
17 5 (29%)
2
(12%)
9 (53%) 1 (6%)
*. 93 individuals participated in the 10 focus groups. Of these 93, 74 (80%) provided information
about their favorite test and 64 (69%) offered information about their least favorite test
**. Data on location was missing from the returned surveys for 10 respondents
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